Metrics Names Stephanie Emory Associate Director of Pharma Development
Will direct team of formulation scientists who develop oral solid dose formulations for Phase I through Phase III clinical trials.
Curbing Malaria’s Spread by Genetic Engineering
Gene drives are being tested as a new approach for combatting the rise of mosquito resistance to pesticides and malaria parasite…
Merck cans one COVID-19 drug, scraps a clinical trial of another
Merck cans one COVID-19 drug, scraps a clinical trial of another…
Alchemab completes £60m Series A funding to advance novel antibody platform
The funding will be used to advance Alchemab’s novel platform to identify disease-modifying antibody therapeutics
BioVersys Gets EIB Funds to Address Antimicrobial Resistance
Financing supports development of BioVersys’ breakthrough hospital antibiotic therapy targeting Acinetobacter baumannii
Loss of Pleasure Linked to Early-Onset Dementia Not Alzheimer’s, New Study Finds
A new study from scientists at the University of Sydney, Australia, shows early-onset dementia or frontotemporal dementia (FTD) is…
GSK stops Keytruda combo trials after ICOS drug falls short
GSK stops Keytruda combo trials after ICOS drug falls short…
Magic mushroom compound psilocybin shows ‘promise’ in depression
Researchers from Imperial College London say compound is at least as effective as a leading antidepressant in a therapeutic setting